Victory Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,047
| Closed | -$96.6K | – | 2515 |
|
|
2023
Q4 | $96.6K | Buy |
18,047
+955
| +6% | +$5.11K | ﹤0.01% | 2348 |
|
|
2023
Q3 | $73.5K | Hold |
17,092
| – | – | ﹤0.01% | 2344 |
|
|
2023
Q2 | $93.8K | Hold |
17,092
| – | – | ﹤0.01% | 2321 |
|
|
2023
Q1 | $71.8K | Hold |
17,092
| – | – | ﹤0.01% | 2403 |
|
|
2022
Q4 | $47.3K | Buy |
17,092
+4,267
| +33% | +$11.8K | ﹤0.01% | 2458 |
|
|
2022
Q3 | $33K | Buy |
12,825
+536
| +4% | +$1.38K | ﹤0.01% | 2596 |
|
|
2022
Q2 | $44K | Sell |
12,289
-405
| -3% | -$1.45K | ﹤0.01% | 2560 |
|
|
2022
Q1 | $79K | Sell |
12,694
-213
| -2% | -$1.33K | ﹤0.01% | 2546 |
|
|
2021
Q4 | $91K | Sell |
12,907
-352
| -3% | -$2.48K | ﹤0.01% | 2587 |
|
|
2021
Q3 | $93K | Buy |
13,259
+147
| +1% | +$1.03K | ﹤0.01% | 2628 |
|
|
2021
Q2 | $109K | Sell |
13,112
-12,888
| -50% | -$107K | ﹤0.01% | 2590 |
|
|
2021
Q1 | $142K | Buy |
+26,000
| New | +$142K | ﹤0.01% | 2562 |
|
|
2020
Q2 | – | Sell |
-12,264
| Closed | -$28K | – | 2833 |
|
|
2020
Q1 | $28K | Buy |
+12,264
| New | +$28K | ﹤0.01% | 2977 |
|
|
2019
Q4 | – | Sell |
-4,614
| Closed | -$14K | – | 2902 |
|
|
2019
Q3 | $14K | Buy |
+4,614
| New | +$14K | ﹤0.01% | 3153 |
|